The abstract is read at the publisher; the summary is JClub's.
Higher baseline blood phosphorylated-tau217 (p-tau217) in 361 dementia-free Swedish older adults is linked to faster hippocampal and amygdala volume loss over 3–6 years.
- Why it matters: It addresses whether AD-related blood biomarkers track early, region-specific structural brain changes in cognitively unimpaired community-dwelling adults.
- What they did: Baseline p-tau217, neurofilament light chain (NfL), and GFAP were measured, then linear mixed models related them to longitudinal MRI changes in TBTV, ventricles, hippocampus, amygdala, and WMHs.
- The result: p-tau217 predicted steeper hippocampal decline (β*year = -0.047, 95% CI = -0.077 to -0.018) and amygdala shrinkage (β*year = -0.064, 95% CI = -0.105 to -0.022), supporting biomarker-linked early AD-region atrophy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.